Pituitary adenomas can appear as hypermetabolic lesions in (18) F-FDG PET imaging

J Neuroimaging. 2010 Oct;20(4):393-6. doi: 10.1111/j.1552-6569.2008.00347.x.

Abstract

Objective: The 2-deoxy-2-[(18) F] fluoro-D-glucose positron emission tomography (FDG-PET) scan is commonly used in detection and staging of many malignant neoplasms. However, several benign or non-neoplastic conditions avidly accumulate (18) F-FDG, causing ambiguity in interpretation of results. It is unknown whether pituitary adenomas uptake (18) F-FDG and appear positive in PET imaging. Here, we present 2 cases of benign pituitary adenoma with elevated metabolic activity in (18) F-FDG PET scan.

Methods: Medical, neurologic, and psychiatric histories; physical examination findings; laboratory work up results; and pathologic and imaging studies were documented.

Results: The (18) F-FDG-PET images revealed foci of marked FDG uptake in pituitary adenomas of 2 patients.

Conclusion: Pituitary micro- and macro-adenomas may present as hypermetabolic foci on (18) F-FDG PET scan.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / diagnostic imaging*
  • Aged
  • Brain Diseases, Metabolic / diagnostic imaging
  • Diagnosis, Differential
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Middle Aged
  • Pituitary Neoplasms / diagnostic imaging*
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18